Preview
this report's Table of Contents and Preface.
Now, begin your strategic planning for 2010 with an in-depth look at the current
state of anatomic pathology testing across the country.
While the combined anatomic pathology and cytology market rose from $11.8 billion
in 2008 to $12.7 billion in 2009 and anatomic pathology market by itself is
expected to increase by 9.1%, test volume growth has slowed during the recession.
Despite the predicted economic recovery, pathologists face daunting challenges
in the years ahead such as reimbursement, developing new client business, competition
from the large commercial labs, specialty physician groups insourcing pathology,
and the costs of acquiring or using new technology.
This report provides a variety of strategies to help you deal with these challenges,
including:
- forming relationships with the large commercial labs
- expanding outreach activities and upgrading of information services
- keeping electronic health record in physician offices
- increasing marketing activities
- expanding sales forces to generate more business
- and much more
In addition, the report includes extensive appendices, including the top 100
anatomic pathology labs; extensive profiles of leading AP labs; and a list of
the top 60 Medicare Part B anatomic pathology procedures.
Based on on data from the 2nd National Market for Anatomic Pathology Services
study conducted early in 2009, and featuring presentations from scores of pathologists
and interviews with lab industry executives, consultants and government executives,
Business Strategies for Anatomic Pathology is designed to be
your essential guide to successful planning and management of an anatomic pathology
lab in 2010 and beyond.
Contributors: Vijay Aggarwal, PhD, Edward Fody, MD, Stanley J. Geyer, MD, Eric
Glassy, MD, Patricia Hughey, Barry Portugal, Mark Terry, Michael Venrick, MD
